ClassID:

109284

C12N2501/056 - CPC Classification

Classification description:

Active agents used in cell culture processes, e.g. differentation; Adjuvants Immunostimulating oligonucleotides, e.g. CpG

Recent Application in this class:
#1
20250333702
2025-10-30

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

#2
20250101381
2025-03-27

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

#3
20240299544
2024-09-12

CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS

#4
20240287452
2024-08-29

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THERAPEUTIC PROTEINS

#5
20230081163
2023-03-16

B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS

#6
20220282215
2022-09-08

Tumor-infiltrating lymphocytes for adoptive cell therapy

#7
20220064260
2022-03-03

ISOLATED MHC-DERIVED HUMAN PEPTIDES AND USES THEREOF FOR STIMULATING AND ACTIVATING THE SUPPRESSIVE FUNCTION OF CD8+CD45RCLOW TREGS

#8
20220002672
2022-01-06

Methods of producing T cell populations enriched for stable regulatory T-cells

#9
20210388060
2021-12-16

NOVEL METHOD FOR PRODUCING ANTIBODIES

#10
20200102540
2020-04-02

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

#11
20200087627
2020-03-19

METHODS OF EXTRACTING HEMATOPOIETIC CELLS FROM BONE MARROW EX VIVO

#12
20190224302
2019-07-25

Generation of HPV-specific T-cells

#13
20190177693
2019-06-13

Tumor-infiltrating lymphocytes for adoptive cell therapy

#14
20180282692
2018-10-04

Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins

#15
20180272037
2018-09-27

Devices for supporting regeneration of body tissues, and methods of making and using them

#16
20180250379
2018-09-06

Generation of HPV-specific T-cells

#17
20180094246
2018-04-05

Method of making cardiomyocytes from human pluripotent cells

#18
20170022478
2017-01-26

Methods of producing T cell populations enriched for stable regulatory T-cells

#19
20160168257
2016-06-16

Molecules that bind CD180, compositions and methods of use

#20
20150125956
2015-05-07

Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same

#21
20140072596
2014-03-13

Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases

#22
20120301959
2012-11-29

Cryoconserved mature dendritic cells

#23
20120020965
2012-01-26

Molecules that bind CD180, compositions and methods of use

#24
20120010597
2012-01-12

Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)

#25
20120009681
2012-01-12

PLATFORM OF DENDRITIC CELL (DC)-BASED VACCINATION

#26
20110300129
2011-12-08

SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY

#27
20110033421
2011-02-10

METHODS RELATED TO IMMUNOSTIMULATORY NUCLEIC ACID-INDUCED INTERFERON

#28
20100303868
2010-12-02

EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES

#29
20100278873
2010-11-04

STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28

#30
20100203630
2010-08-12

In vitro human B lymphopoiesis culture system

#31
20100167332
2010-07-01

Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)

#32
20090148405
2009-06-11

INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) RECEPTOR LIGANDS

#33
20090098090
2009-04-16

VITRO IMMUNIZATION

#34
20090004157
2009-01-01

Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use

#35
20080267994
2008-10-30

Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)

#36
20080241176
2008-10-02

Method for rapid generation of mature dendritic cells

#37
20080199423
2008-08-21

Methods of Using Apo2l Receptor Agonists and Ink Cell Activators

#38
20070154877
2007-07-05

Method for the direct culture of dendritic cells without a preceding centrifugation step

#39
20070071717
2007-03-29

Treatment of B cells with IL-21 and B cell activators induces Granzyme B production

#40
20070065467
2007-03-22

Immunostimulatory nucleic acid molecules for activating dendritic cells

#41
20060286070
2006-12-21

Methods related to immunostimulatory nucleic acid-induced interferon

#42
20060228342
2006-10-12

Method for generating antigen-presenting cells

#43
20060147427
2006-07-06

Method for immunotherapy of tumors

#44
20050239734
2005-10-27

C-class oligonucleotide analogs with enhanced immunostimulatory potency

#45
20050169888
2005-08-04

Methods related to immunostimulatory nucleic acid-induced interferon

#46
20050003533
2005-01-06

Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use